All In MedTech

FDA Clearance Tracker · P190015-S026

TREO® Abdominal Stent-Graft System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 26, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 26, 2026

Approved

Time to decision

177 days

Received Sep 30, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190015-S026
Device name
TREO® Abdominal Stent-Graft System
Applicant location
Sunrise, FL
Received
Sep 30, 2025
Decided
Mar 26, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P190015

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

approval for the addition of 140mm contralateral length TREO Main Bifurcated Stent Graft size and modifications to the TREO B2/C2 delivery system

Source documents

Other decisions for Bolton Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.